Hybrid Compounds & Oxidative Stress Induced Apoptosis in Cancer Therapy

Hanikoglu A., Ozben H., Hanikoglu F., Ozben T.

CURRENT MEDICINAL CHEMISTRY, cilt.27, sa.13, ss.2118-2132, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 27 Sayı: 13
  • Basım Tarihi: 2020
  • Doi Numarası: 10.2174/0929867325666180719145819
  • Dergi Adı: CURRENT MEDICINAL CHEMISTRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Agricultural & Environmental Science Database, BIOSIS, Chemical Abstracts Core, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.2118-2132
  • Anahtar Kelimeler: Cancer, oxidative stress, antioxidants, redox, apoptosis, hybrid compounds, BIOLOGICAL EVALUATION, POTENTIAL ANTICANCER, ANTIPROLIFERATIVE ACTIVITY, TRIAZOLE HYBRIDS, CHALCONE ANALOGS, AGENTS DESIGN, BREAST-CANCER, NITRIC-OXIDE, DERIVATIVES, CURCUMIN
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Elevated Reactive Oxygen Species (ROS) generated by the conventional cancer therapies and the endogenous production of ROS have been observed in various types of cancers. In contrast to the harmful effects of oxidative stress in different pathologies other than cancer, ROS can speed anti-tumorigenic signaling and cause apoptosis of tumor cells via oxidative stress as demonstrated in several studies. The primary actions of antioxidants in cells are to provide a redox balance between reduction-oxidation reactions. Antioxidants in tumor cells can scavenge excess ROS, causing resistance to ROS induced apoptosis. Various chemotherapeutic drugs, in their clinical use, have evoked drug resistance and serious side effects. Consequently, drugs having single-targets are not able to provide an effective cancer therapy. Recently, developed hybrid anticancer drugs promise great therapeutic advantages due to their capacity to overcome the limitations encountered with conventional chemotherapeutic agents. Hybrid compounds have advantages in comparison to the single cancer drugs which have usually low solubility, adverse side effects, and drug resistance. This review addresses two important treatments strategies in cancer therapy: oxidative stress induced apoptosis and hybrid anticancer drugs.